These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21493870)
1. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Davis-Dao CA; Henderson KD; Sullivan-Halley J; Ma H; West D; Xiang YB; Gago-Dominguez M; Stern MC; Castelao JE; Conti DV; Pike MC; Bernstein L; Cortessis VK Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1156-70. PubMed ID: 21493870 [TBL] [Abstract][Full Text] [Related]
2. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies. Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589 [TBL] [Abstract][Full Text] [Related]
3. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study. Daugherty SE; Lacey JV; Pfeiffer RM; Park Y; Hoover RN; Silverman DT Int J Cancer; 2013 Jul; 133(2):462-72. PubMed ID: 23319449 [TBL] [Abstract][Full Text] [Related]
4. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis. Dietrich K; Demidenko E; Schned A; Zens MS; Heaney J; Karagas MR Eur J Cancer; 2011 Mar; 47(4):592-9. PubMed ID: 21067913 [TBL] [Abstract][Full Text] [Related]
5. Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women. Kabat GC; Kim MY; Luo J; Hou L; Cetnar J; Wactawski-Wende J; Rohan TE Eur J Cancer Prev; 2013 Sep; 22(5):409-16. PubMed ID: 23442343 [TBL] [Abstract][Full Text] [Related]
6. Parity and bladder cancer risk: a dose-response meta-analysis. Bai Y; Wang X; Yang Y; Tang Y; Wang J; Han P BMC Cancer; 2017 Jan; 17(1):31. PubMed ID: 28061845 [TBL] [Abstract][Full Text] [Related]
7. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Cantwell MM; Lacey JV; Schairer C; Schatzkin A; Michaud DS Int J Cancer; 2006 Nov; 119(10):2398-401. PubMed ID: 16894568 [TBL] [Abstract][Full Text] [Related]
8. Bladder cancer and reproductive factors among women in Spain. Huang AT; Kogevinas M; Silverman DT; Malats N; Rothman N; Tardón A; Serra C; García-Closas R; Carrato A; Cantor KP Cancer Causes Control; 2009 Dec; 20(10):1907-13. PubMed ID: 19568699 [TBL] [Abstract][Full Text] [Related]
9. Reproductive and hormonal factors and bladder cancer risk: a prospective study and meta-analysis. Xu X; Mo Q; Shen H; Wang S; Liu B Aging (Albany NY); 2020 Jul; 12(14):14691-14698. PubMed ID: 32629427 [TBL] [Abstract][Full Text] [Related]
10. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Weibull CE; Eloranta S; Altman D; Johansson AL; Lambe M Eur Urol; 2013 Apr; 63(4):733-8. PubMed ID: 23332884 [TBL] [Abstract][Full Text] [Related]
11. Bladder cancer, parity, and age at first birth. Cantor KP; Lynch CF; Johnson D Cancer Causes Control; 1992 Jan; 3(1):57-62. PubMed ID: 1536914 [TBL] [Abstract][Full Text] [Related]
12. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Ross RK; Paganini-Hill A; Wan PC; Pike MC J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Ma H; Henderson KD; Sullivan-Halley J; Duan L; Marshall SF; Ursin G; Horn-Ross PL; Largent J; Deapen DM; Lacey JV; Bernstein L Breast Cancer Res; 2010; 12(3):R35. PubMed ID: 20565829 [TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818 [TBL] [Abstract][Full Text] [Related]
15. Use of oral contraceptives and risk of breast cancer in young women. Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222 [TBL] [Abstract][Full Text] [Related]
16. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
17. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. McTiernan AM; Weiss NS; Daling JR Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918 [TBL] [Abstract][Full Text] [Related]
18. Abortion and the risk of breast cancer: a case-control study in Greece. Lipworth L; Katsouyanni K; Ekbom A; Michels KB; Trichopoulos D Int J Cancer; 1995 Apr; 61(2):181-4. PubMed ID: 7705945 [TBL] [Abstract][Full Text] [Related]
19. Estrogen exposure and bladder cancer risk in Egyptian women. Wolpert BJ; Amr S; Ezzat S; Saleh D; Gouda I; Loay I; Hifnawy T; Mikhail NN; Abdel-Hamid M; Zhan M; Zheng YL; Squibb K; Abdel-Aziz MA; Zaghloul M; Khaled H; Loffredo CA Maturitas; 2010 Dec; 67(4):353-7. PubMed ID: 20813471 [TBL] [Abstract][Full Text] [Related]
20. Can reproductive characteristics predict bladder cancer in women with haematuria? Yavuzcan A; Caglar M; Kayikci MA; Basaran E; Tekin A; Ozdemir E; Dilbaz S; Ustun Y; Cam HK Asian Pac J Cancer Prev; 2013; 14(9):5107-10. PubMed ID: 24175784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]